Envista Holdings Corporation $NVST Shares Sold by Clarkston Capital Partners LLC

Clarkston Capital Partners LLC reduced its holdings in Envista Holdings Corporation (NYSE:NVST) by 71.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,182,055 shares of the company’s stock after selling 3,029,680 shares during the period. Envista comprises 2.3% of Clarkston Capital Partners LLC’s holdings, making the stock its 14th biggest position. Clarkston Capital Partners LLC’s holdings in Envista were worth $29,989,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Caitong International Asset Management Co. Ltd lifted its position in Envista by 16,711.1% during the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after purchasing an additional 1,504 shares during the period. Allworth Financial LP raised its stake in shares of Envista by 75.4% during the 4th quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after buying an additional 776 shares during the last quarter. UMB Bank n.a. raised its stake in shares of Envista by 46.1% during the 4th quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock valued at $44,000 after buying an additional 636 shares during the last quarter. IFP Advisors Inc lifted its holdings in shares of Envista by 102.9% in the 4th quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock valued at $46,000 after buying an additional 1,071 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Envista by 73.1% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock valued at $44,000 after buying an additional 949 shares during the period.

Envista Trading Down 1.1%

Shares of Envista stock opened at $26.14 on Friday. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.44 and a quick ratio of 2.06. The stock’s 50 day simple moving average is $25.13 and its 200-day simple moving average is $25.74. The stock has a market cap of $4.25 billion, a P/E ratio of 63.75, a P/E/G ratio of 1.50 and a beta of 0.86. Envista Holdings Corporation has a 1-year low of $18.77 and a 1-year high of $30.42.

Envista (NYSE:NVST) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.31 by $0.05. Envista had a return on equity of 7.11% and a net margin of 2.41%.The firm had revenue of $705.50 million during the quarter, compared to analysts’ expectations of $680.03 million. During the same quarter last year, the firm earned $0.24 earnings per share. The business’s revenue for the quarter was up 14.4% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Analysts predict that Envista Holdings Corporation will post 1.42 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms recently commented on NVST. Evercore reaffirmed an “outperform” rating and set a $33.00 target price on shares of Envista in a report on Thursday, May 7th. Citigroup started coverage on shares of Envista in a research note on Wednesday, April 15th. They issued a “neutral” rating and a $29.00 target price for the company. Zacks Research downgraded Envista from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 6th. Weiss Ratings lowered Envista from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. Finally, JPMorgan Chase & Co. upped their target price on Envista from $26.00 to $29.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. Six research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $28.54.

Envista Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.